These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 27550978)
1. Medication-Assisted Treatment of Adolescents With Opioid Use Disorders. COMMITTEE ON SUBSTANCE USE AND PREVENTION Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27550978 [TBL] [Abstract][Full Text] [Related]
2. Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions. Chang DC; Klimas J; Wood E; Fairbairn N Am J Drug Alcohol Abuse; 2018; 44(2):143-146. PubMed ID: 29190156 [TBL] [Abstract][Full Text] [Related]
3. Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults. Viera A; Bromberg DJ; Whittaker S; Refsland BM; Stanojlović M; Nyhan K; Altice FL Epidemiol Rev; 2020 Jan; 42(1):41-56. PubMed ID: 32239206 [TBL] [Abstract][Full Text] [Related]
5. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Connery HS Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920 [TBL] [Abstract][Full Text] [Related]
6. The science and practice of medication-assisted treatments for opioid dependence. Pecoraro A; Ma M; Woody GE Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570 [TBL] [Abstract][Full Text] [Related]
7. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults. Cottrill CB; Matson SC Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312 [No Abstract] [Full Text] [Related]
8. Buprenorphine Treatment for Opioid Use Disorder: An Overview. Shulman M; Wai JM; Nunes EV CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259 [TBL] [Abstract][Full Text] [Related]
9. Medication-assisted treatment for opioid use disorder. Kaplan L Nurse Pract; 2019 Mar; 44(3):10-12. PubMed ID: 30585906 [No Abstract] [Full Text] [Related]
10. Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World. Parrino MW; Maremmani AG; Samuels PN; Maremmani I J Addict Dis; 2015; 34(2-3):255-62. PubMed ID: 26110357 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Substance Use Disorders. Klein JW Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620 [TBL] [Abstract][Full Text] [Related]
12. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial. Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653 [TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961 [TBL] [Abstract][Full Text] [Related]
14. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment. Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846 [TBL] [Abstract][Full Text] [Related]
15. Use of Buprenorphine to Treat Opioid Use Disorder. Bartholow LAM; Pope J J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Treatment of Opioid Use Disorder in 2020. Wakeman SE JAMA; 2020 May; 323(20):2082-2083. PubMed ID: 32329798 [No Abstract] [Full Text] [Related]
17. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016. Shastry S; Manini AF; Richardson LD; Lin MP J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352 [No Abstract] [Full Text] [Related]
18. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential. Sigmon SC; Bigelow GE Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982 [No Abstract] [Full Text] [Related]
19. Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021. Vidyasagar N; Bunting SR; Arora VM; Ari M JAMA; 2024 Feb; 331(6):524-526. PubMed ID: 38236586 [TBL] [Abstract][Full Text] [Related]
20. Perioperative Management and Analgesia for Patients Taking Buprenorphine and Other Forms of Medication-Assisted Treatment for Substance Abuse Disorders. Scholzen E; Zeng AM; Schroeder KM Adv Anesth; 2019 Dec; 37():65-86. PubMed ID: 31677660 [No Abstract] [Full Text] [Related] [Next] [New Search]